Novartis AG
NVSEF | OTC
$138.38
+$0.13 (+0.09%)
Sep 22, 2026, 4:00 PM ET · Market open
TTM Period Ending | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 | Q4 2020 Dec 30, 2020 | Q3 2020 Sep 29, 2020 | Q2 2020 Jun 29, 2020 | Q1 2020 Mar 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 13.71B | 12.96B | 11.95B | 11.77B | 10.02B | 9.07B | 8.76B | 7.59B | 7.65B | 7.03B | 6.96B | 21.8B | 22.98B | 24.18B | 24.02B | 9.81B | 8.99B | 7.96B | 8.07B | 7.1B | 7.21B | 7.45B |
Depreciation & Amortization | 6.05B | 5.96B | 6.08B | 6.04B | 7.14B | 7.8B | 8.52B | 8.88B | 7.8B | 7.77B | 7.18B | 6.75B | 6.18B | 5.82B | 6.11B | 6.21B | 6.49B | 6.75B | 6.46B | 6.78B | 6.45B | 5.8B |
Stock-Based Compensation | 1.06B | 1.05B | 1.04B | 1.02B | 970M | 935M | 865M | 814M | 828M | 810M | 823M | 821M | 775M | 756M | 736M | 700M | 729M | 743M | 738M | 749M | 763M | 738M |
Other Working Capital | 359.51M | 153.24M | -77.4M | -275.4M | 512.66M | 434.93M | 1.16B | 1.85B | 1.26B | 694M | -1.2B | 31M | -480M | -296M | 241M | 287M | -158M | 362M | -291M | -657M | 70M | -637M |
Other Non-Cash Items | -1.69B | 1.68B | 6.59B | 6.31B | 6.12B | 1.5B | -3.51B | -2.59B | -1.84B | -993M | -1.14B | -16.73B | -17.15B | -18.05B | -18.16B | -3.75B | -4.57B | -4.31B | -3.14B | -2.77B | -1.77B | -1.58B |
Deferred Income Tax | 1.97B | 2.06B | 1.7B | 975M | 814M | 671M | 676M | 1.21B | 1.52B | 1.41B | 1.42B | 1.79B | 1.91B | 2.18B | 2.12B | 1.93B | 1.94B | 1.75B | 1.81B | 1.98B | 1.87B | 1.97B |
Change in Working Capital | -308.42M | -839.59M | -1.3B | -1.69B | -1.56B | -1.63B | -872M | 97M | -604M | -496M | -1B | -412M | -480M | -296M | 241M | 287M | -158M | 362M | -291M | -657M | 70M | -637M |
Operating Cash Flow | 20.79B | 18.99B | 17.54B | 15.89B | 14.98B | 13.7B | 14.46B | 16.02B | 15.37B | 15.54B | 14.24B | 14.01B | 14.21B | 14.59B | 15.07B | 15.19B | 13.42B | 13.25B | 13.65B | 13.19B | 14.59B | 13.74B |
Capital Expenditures | -2.74B | -2.92B | -3.79B | -3.44B | -3.33B | -3.58B | -2.93B | -2.8B | -2.7B | -2.28B | -2.67B | -3B | -2.96B | -2.97B | -2.97B | -3.02B | -3.11B | -2.96B | -2.58B | -2.2B | -2.13B | -2.12B |
Cash Acquisitions | -1.96B | -3.54B | -3.8B | -3.55B | -6.98B | -3.81B | -3.59B | -3.59B | -131M | -106M | -903M | 19.44B | 19.42B | 19.47B | 20.1B | -177M | -272M | -272M | -9.96B | -9.94B | -13.29B | -13.57B |
Purchase of Investments | -3.43B | -3.65B | -3.64B | -1.91B | -940.37M | -691.46M | -750M | -10.76B | -17.43B | -30.67B | -34.82B | -39.87B | -33.97B | -20.78B | -16.61B | -1.14B | -1.87B | -1.89B | -2.13B | -2.09B | -691M | -699M |
Sales Maturities Of Investments | 4.04B | 5.06B | 3.72B | 3.32B | 2.1B | 1.09B | 11.6B | 21.08B | 33.25B | 35.35B | 39.49B | 30.52B | 18.08B | 16.18B | 2.76B | 2.38B | 2.51B | 2.45B | 1.22B | 1.38B | 1.86B | 1.88B |
Other Investing Acitivies | -1.25B | -1B | -1.44B | -1.52B | 682.79M | 673M | 1.27B | 1.95B | 301M | 431M | 368M | -104M | -204M | -83M | -662M | -549M | -743M | -1.27B | -1.03B | -439M | -237M | 26M |
Investing Cash Flow | -5.32B | -6.27B | -7.47B | -6.19B | -8.03B | -5.9B | 5.6B | 5.89B | 13.3B | 2.72B | 1.47B | 7.5B | 1.07B | 12.79B | 4.21B | -926M | -1.74B | -2.26B | -13.18B | -12.29B | -13.65B | -13.7B |
Debt Repayment | 2.12B | 2.78B | 4.39B | 5.11B | 310M | -1.26B | -1.48B | -3.34B | -2.92B | -2.18B | -2.71B | -2.2B | -1.49B | -1.57B | -1.21B | -573M | 3.4B | 1.23B | 8.01B | 7.01B | 4.01B | 6.18B |
Common Stock Repurchased | -11.05B | -9.95B | -8.33B | -6.82B | -5.59B | -6.93B | -8.72B | -10.15B | -11.24B | -11B | -10.65B | -8.12B | -5.69B | -3.68B | -3.06B | -4.68B | -5.32B | -4.62B | -2.84B | -1.08B | -3.09B | -5.45B |
Dividend Paid | -7.74B | -7.73B | -7.45B | -7.5B | -7.64B | -5.26B | -7.55B | -7.54B | -7.52B | -7.58B | -7.75B | -7.74B | -7.72B | -7.57B | -7.43B | -7.39B | -7.39B | -7.37B | -6.99B | -6.99B | -6.99B | -6.99B |
Other Financial Acitivies | -364.02M | -191.92M | -400.17M | -242.31M | 2.88B | 2.97B | 3.18B | 3.27B | 67.79M | 585.05M | 695.05M | -1.79B | -1.77B | -4.5B | -4.62B | -3.33B | -3.23B | -1B | -386M | 574.03M | 978.03M | 3.33B |
Financial Cash Flow | -17.14B | -15.18B | -11.64B | -9.25B | -9.7B | -10.08B | -14.28B | -17.67B | -21.57B | -20.24B | -20.56B | -19.82B | -16.62B | -17.25B | -16.26B | -15.95B | -12.52B | -11.76B | -2.21B | -475M | -5.09B | -2.93B |
Net Cash Flow | -1.25B | -2.39B | -1.93B | 1.2B | -2.98B | -2.54B | 5.88B | 3.68B | 7.26B | -1.85B | -4.89B | 1.52B | -1.49B | 10.05B | 2.75B | -1.78B | -800M | -727M | -1.45B | 616M | -4.07B | -2.28B |
Free Cash Flow | 18.05B | 16.06B | 13.75B | 12.45B | 11.66B | 10.11B | 11.53B | 13.23B | 12.67B | 13.26B | 11.57B | 11.01B | 11.26B | 11.62B | 12.1B | 12.18B | 10.32B | 10.29B | 11.07B | 10.99B | 12.46B | 11.62B |
Adj. Free Cash Flow | 16.99B | 15.02B | 12.7B | 11.43B | 10.69B | 9.18B | 10.66B | 12.41B | 11.84B | 12.45B | 10.74B | 10.19B | 10.48B | 10.86B | 11.36B | 11.48B | 9.59B | 9.55B | 10.33B | 10.24B | 11.7B | 10.88B |
Maintenance CapEx | -2.01B | -2.19B | -3.06B | -3.17B | -3.33B | -3.35B | -2.59B | -2.46B | -2.36B | -2.17B | -2.64B | -2.82B | -2.53B | -2.06B | -2.09B | -2.18B | -2.5B | -2.85B | -2.09B | -1.8B | -1.42B | -1.41B |
Growth CapEx | -729.61M | -729.61M | -729.61M | -275.32M | n/a | -231.45M | -338.6M | -338.6M | -338.6M | -107.16M | -33.97M | -179.08M | -423.57M | -916.7M | -882.73M | -832.57M | -605.01M | -111.89M | -490.8M | -395.84M | -715.02M | -715.02M |
Owner Earnings | 18.78B | 16.79B | 14.48B | 12.72B | 11.66B | 10.35B | 11.86B | 13.56B | 13.01B | 13.37B | 11.6B | 11.19B | 11.68B | 12.53B | 12.98B | 13.01B | 10.92B | 10.4B | 11.56B | 11.39B | 13.17B | 12.34B |
Add to Watchlist
Select watchlists to add or remove NVSEF